ENGLISH
|
JAPANESE
|
CONNECT WITH US:
Home
About
Contact
Log in
*
Home
Press release
Nov 02, 2021 09:30 JST
Source:
Cryoviva Singapore
Cryoviva Singapore Gets AABB Accreditation for Somatic Cells' Processing, Storage, and Distribution
Fast growing company becomes first family cord blood bank to get AABB accreditation for both cord blood and somatic cells' services in Singapore. Parents can confidently store both umbilical cord blood and cord tissue with Cryoviva's internationally accredited facility here.
Singapore, Nov 02, 2021 - (ACN Newswire) - Family cord blood bank Cryoviva Singapore is pleased to announce that it has now been accredited by the Association of the Advancement of Blood & Biotherapies (AABB), formerly known as the American Association of Blood Banks, for both cord blood and somatic cells' banking services. Cryoviva is the first family cord blood bank in Singapore to get accredited by AABB for Somatic Cells' processing, storage, and distribution.
The company had already been accredited by AABB previously for Cord blood collection, storage, processing and distribution, an accreditation that has been successfully extended until September 30, 2023.
The news of the AABB accreditation for both cord blood and somatic cells' services closely follows Cryoviva's recent expansions into the Middle East. The company is now serving families in the UAE and Bahrain, enabling them to store their baby's precious umbilical cord blood at Cryoviva's world-class facilities in Singapore.
"We are indeed proud to get the AABB accreditations and being the first private cord blood bank to get it for somatic cells' processing, storage and distribution. It has been our constant endeavour to offer families the greatest opportunities to benefit from the potential of umbilical cord stem cells," said Rajesh Nair, CEO of Cryoviva Singapore. "Cord tissue storage- in addition to cord blood banking- is a significant step in this regard, which we believe will benefit a lot more families. We will continue to invest in the right technologies, processes and people to ensure we offer the very best service to our valued customers."
"Since commencing our operations in Singapore 7 years ago, Cryoviva has made rapid progress in establishing itself in the family cord blood space. This is another important milestone for us. Besides the company's management and investors, our team of medical experts and lab staff deserve credit for their commitment to quality and excellence," said Dr.Toh Keng Kiat, Medical Director of Cryoviva Singapore and a reputed haematologist.
About Cryoviva Singapore
Established in 2014, Cryoviva (
https://cryoviva.com.sg
) is a reputed family cord blood bank in Singapore. The company is part of an international group that is backed by reputed multinational investor organisations. Cryoviva has successfully stored over 160,000 umbilical cord blood units from both local and expat clients at our state-of-the-art laboratory and storage facility in Singapore. This facility is MoH-licensed, AABB accredited and IS ISO 9001:2015 QMS Certified, testaments to the stringent processes and quality standards that we adhere to. Thanks to being centrally located and proximity to most major maternity hospitals in Singapore, cord blood samples reach our facilities very quickly and efficiently to ensure top quality maintenance upon storage.
Media Contact:
Krish Sharma, Sr.Manager, Marketing & Operations
Tel: +65-9651 7080
E-mail:
krish@cryoviva.com.sg
Source: Cryoviva Singapore
Sectors: BioTech, Healthcare & Pharm, MedTech
Copyright ©2025 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
Latest Release
TANAKA PRECIOUS METAL GROUP Announces Business Partnership with JEPLAN to Realize a Decarbonized, Circular Society
Jul 31, 2025 15:00 JST
DENSO Announces First Quarter Financial Results
Jul 31, 2025 11:25 JST
Honda Launches All-New Prelude Teaser Page Ahead of Scheduled September 2025 Market Introduction
Jul 31, 2025 11:20 JST
MHI Demonstrates Transport of Relief Supplies in the Event of a Disaster Using Uncrewed Aerial Vehicles Currently in Development
Jul 31, 2025 11:00 JST
Early Alzheimer's Patients Continue to Benefit from Four Years of LEQEMBI(R) (lecanemab-irmb) Therapy New Clinical Data Presented at AAIC
Jul 31, 2025 09:30 JST
New Data Presented at AAIC Demonstrates Investigational LEQEMBI(R) (lecanemab-irmb) 360 mg Subcutaneous Maintenance Dosing Could Offer a New Option for Ongoing Treatment of Early Alzheimer's Disease
Jul 31, 2025 09:20 JST
Two-Year Real-World Study of LEQEMBI(R) in the United States Presented at Alzheimer's Association International Conference (AAIC) 2025
Jul 31, 2025 09:10 JST
Introducing the Meshy 5 Preview: Smarter AI, Cleaner Models, Bigger Animation Potential
Jul 30, 2025 22:41 JST
Production, Sales and Export Results for June, 2025
Jul 30, 2025 18:24 JST
Sales, Production, and Export Results for the First Half of 2025
Jul 30, 2025 18:06 JST
Collaborative Development of Ultra-Compact and Lightweight Satellite Communication User Terminals for Mobility with Mitsubishi Chemical, NICT, and TECHLAB
Jul 30, 2025 11:00 JST
Mitsubishi Heavy Industries Concludes Agreement with Modius to Provide DCIM Solutions for Data Centers Worldwide
Jul 29, 2025 20:00 JST
Set at the Osaka-Kansai Expo venue! Detailed program announced for the "OSAKA JAPAN SDGs Forum"
Jul 29, 2025 14:30 JST
LENVIMA(R) (lenvatinib) in Combination with Pembrolizumab and Transarterial Chemoembolization (TACE) Approved in China for the Treatment of Unresectable, Non-Metastatic Hepatocellular Carcinoma
Jul 29, 2025 09:01 JST
Olympus Enters Strategic Partnership to Develop Endoluminal Gastrointestinal Robotics
Jul 25, 2025 16:00 JST
Eisai Listed for 24th Consecutive Year in FTSE4Good Index Series, an Index for Socially Responsible Investment
Jul 25, 2025 13:31 JST
Fujitsu and Nagoya University develop simulation tech to combat transportation gaps
Jul 24, 2025 12:30 JST
Honda Reveals Details of its Support of the World Athletics Championships Tokyo 25
Jul 24, 2025 12:03 JST
Prototype divertor outer vertical target for the ITER fusion experimental reactor is completed and the sample has passed the ITER Organization's certification test
Jul 23, 2025 13:10 JST
Sharp Exhibits at the 2nd SPEXA - International Space Business Expo
Jul 23, 2025 10:30 JST
More Latest Release >>
Related Release
Singapore family cord blood bank Cryoviva upgrades to AXP II System for cord blood processing
March 21 2023 08:30 JST
Cryoviva Singapore Expands Cord Blood Banking Services to Bahrain
September 07 2021 12:20 JST
Singapore cord blood bank Cryoviva establishes footprint in the UAE
July 27 2021 08:00 JST
More Press release >>